Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

  • There is currently no data for MIX

Interim Management Statement

14 May 2012 11:02

Matrix Income & Growth VCT plc (the Company) INTERIM MANAGEMENT STATEMENT For the quarter ended 31 March 2012

In accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UKListing Authority, Matrix Income & Growth VCT plc presents an InterimManagement Statement for the quarter ended 31 March 2012. The statement alsoincludes relevant financial information between the end of the period and thedate of this statement.

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 31 March 2012 At 31 December

2011

Net assets attributable to shareholders £41,915,672 £40,726,175 Shares in issue 43,444,512 42,606,052 Net asset value per Ordinary Share 96.48 p 95.59 p Cumulative dividends paid 26.80 p 26.80 p Total return (net asset value basis) 123.28 p 122.39 pper share since inception % return on opening net asset value 30.46 % 29.51 %per share of 94.5 pence

The net asset value per share has risen by 0.89 pence over the quarter. This is primarily due to a positive income return in the quarter.

CUMULATIVE DIVIDENDS

A final dividend of 6.25 pence per share comprising 1.25 pence from income and5.00 pence from capital in respect of the year ended 31 December 2011 wasapproved by shareholders at the Annual General Meeting of the Company held on10 May 2012. The dividend will be payable on 22 May 2012 to Shareholders whoare on the Register on 11 May 2012. This dividend, once paid, will increasecumulative dividends paid since inception to 33.05 pence per share.

NEW INVESTMENTS

The Company continued its Operating Partner programme, which resulted in further new investment in the quarter of £4 million, with a further £3 million invested after the quarter-end.

LOAN STOCK REPAYMENTS

In January, Fullfield Limited made a partial repayment of its loan stock of

£122,692 and Focus Pharma Holdings Limited repaid £269,708 of its loan stock, together with a premium of £121,045.

SHARE BUYBACKS

The Company bought back 925,000 of its own Ordinary Shares at an average priceof 82.78 pence during the quarter ended 31 March 2012. Since the end of theperiod, it has bought back a further 247,320 of its own shares at a price of85.84 pence.

MATRIX VCTs' LINKED OFFER FOR SUBSCRIPTION

During the quarter ended 31 March 2012, the Company issued and allotted a total of 1,763,460 ordinary shares at a price of £1.012 per share, raising net proceeds of £1,690,204 (after deducting initial costs).

Since the quarter end the Company has allotted a further 3,118,113 ordinary shares at a price of £1.012 per share, raising further net proceeds of £2,985,810 (after deducting initial costs).

Applications totalling £14.5 million have been received to date under the Offer of which £4.8 million has been received for Matrix Income & Growth VCT plc.

The Offer remains open until 30 June 2012.

For further information, please contact:

Sarah Penfold, for Matrix Private Equity Partners LLP, Company Secretary: 020 3206 7000.

XLON
Date   Source Headline
1st Dec 20237:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20231:30 pmRNSInterim Management Statement
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20231:00 pmRNSTransaction in Own Shares
21st Sep 202310:15 amRNSDividend Declaration
18th Sep 20231:00 pmRNSHalf-year Report
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:00 pmRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSInterim Management Statement
2nd May 202310:00 amRNSTotal Voting Rights
19th Apr 202310:00 amRNSTransaction in Own Shares
13th Apr 20231:00 pmRNSDividend Declaration
4th Apr 20236:07 pmRNSAnnual Financial Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
1st Mar 20237:00 amRNSTotal Voting Rights
6th Feb 20236:20 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:06 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
17th Jan 20235:16 pmRNSDirector Declaration
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
22nd Dec 20229:34 amRNSTransaction in Own Shares
5th Dec 20225:49 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited
28th Nov 20228:34 amRNSTransaction in Own Shares and total voting rights
17th Nov 20227:00 amRNSDirector/PDMR Shareholding
16th Nov 20225:41 pmRNSIssue of Equity and Total Voting Rights
9th Nov 20223:40 pmRNSNet Asset Value(s)
9th Nov 20223:00 pmRNSInterim Management Statement
17th Oct 20221:52 pmRNSOffer for Subscription – Update
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
12th Oct 20224:05 pmRNSResult of Meeting
10th Oct 202212:00 pmRNSTransaction in Own Shares
5th Oct 20221:50 pmRNSOffers for Subscription and Issue of Prospectus
26th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20223:00 pmRNSFundraising Update, Circular and General Meetings
5th Sep 20224:20 pmRNSHalf-year Report
15th Aug 20227:00 amRNSIntention To Launch Joint Offers For Subscription
2nd Aug 20227:00 amRNSNet Asset Value(s)
13th Jun 20222:00 pmRNSRealisation of investment - Media Business Insight

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.